ArticleClinical Outcomes for Patients with Acute Myeloid Leukemia Harboring IDH1 Mutation After Intensive Chemotherapy
ArticleClinical Outcomes for Patients with Acute Myeloid Leukemia Harboring IDH1 Mutation After Intensive Chemotherapy
ArticlePROTEIN ARGININE METHYLTRANSFERASE 1 EXPRESSION LEVEL AND ITS PROGNOSTIC SIGNIFICANCE IN ADULT ACUTE MYELOID LEUKEMIA PATIENTS
ArticlePROTEIN ARGININE METHYLTRANSFERASE 1 EXPRESSION LEVEL AND ITS PROGNOSTIC SIGNIFICANCE IN ADULT ACUTE MYELOID LEUKEMIA PATIENTS
Articleprognostic Impact of Pretreatment Serum Lactate Dehydrogenase Levels in Adult Patients with Acute Myeloid Leukemia: Single Center Experience
Articleprognostic Impact of Pretreatment Serum Lactate Dehydrogenase Levels in Adult Patients with Acute Myeloid Leukemia: Single Center Experience
ArticlePrognostic Impact of Flow Cytometric Measurement of G Protein–Coupled Receptor 56 (GPR56) in Acute Myeloid Leukemia
ArticlePrognostic Impact of Flow Cytometric Measurement of G Protein–Coupled Receptor 56 (GPR56) in Acute Myeloid Leukemia
ArticlePrognostic Value of Interleukin-17 A Gene Polymorphism and Serum IL-17 Levels in Adult Acute Myeloid Leukaemia Patients
ArticlePrognostic Value of Interleukin-17 A Gene Polymorphism and Serum IL-17 Levels in Adult Acute Myeloid Leukaemia Patients